publication venue for
- Impact of concomitant medication on clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study.. 12. 2021
- EGFR exon 19-deletion aberrantly regulate ERCC1 expression that may partly impaired DNA damage repair ability in non-small cell lung cancer.. 11. 2019
- Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patients.. 10. 2019